Aliza Leiser
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Reproductive Medicine top 2%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Gil MorThomas RutherfordAyesha B. AlveroPeter E. SchwartzIrene VisintinMichael KellyS. DennisStefan Fest
- Topics
- Ovarian cancer diagnosis and treatment (10 papers)Endometrial and Cervical Cancer Treatments (7 papers)Cancer survivorship and care (4 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Aliza Leiser
27 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Molecular Biology 433
- Cancer Research 404
- Oncology 335
- Reproductive Medicine 301
- Pulmonary and Respiratory Medicine 228
Countries citing papers authored by Aliza Leiser
This map shows the geographic impact of Aliza Leiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aliza Leiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aliza Leiser more than expected).
Fields of papers citing papers by Aliza Leiser
This network shows the impact of papers produced by Aliza Leiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aliza Leiser. The network helps show where Aliza Leiser may publish in the future.
Co-authorship network of co-authors of Aliza Leiser
This figure shows the co-authorship network connecting the top 25 collaborators of Aliza Leiser. A scholar is included among the top collaborators of Aliza Leiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aliza Leiser. Aliza Leiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 57 | |
| 3 | 8 | |
| 4 | 4 | |
| 5 | 92 | |
| 6 | Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkersbreakdown → | 196 |
| 7 | 11 | |
| 8 | 2 | |
| 9 | 25 | |
| 10 | 11 | |
| 11 | 307 | |
| 12 | 255 | |
| 13 | 53 | |
| 14 | 13 | |
| 15 | 51 | |
| 16 | 27 | |
| 17 | 8 | |
| 18 | 3 | |
| 19 | 44 | |
| 20 | 27 |
About Aliza Leiser
Aliza Leiser is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Cancer Research, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Cancer survivorship and care (4 papers). The work is most often cited by research in Reproductive Medicine (301 citations), Obstetrics and Gynecology (213 citations) and Cancer Research (404 citations). Aliza Leiser has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Gil Mor, Thomas Rutherford, Ayesha B. Alvero, Peter E. Schwartz, Irene Visintin, Michael Kelly, S. Dennis, Stefan Fest, Ryan Chen and Dan‐Arin Silasi. Their work appears in journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.